| Latest | F'cast | |
|---|---|---|
| Div Yield | 1.5% | 1.6% |
| Div Cover | 5.4 | 5.6 |
| Op Mrgn | 16.6% | 16.8% |
| ROCE | 15.8% |
| Latest | F'cast | |
|---|---|---|
| P/E | 12.5 | 10.8 |
| PEG | 1.2 | 0.7 |
| Pr/Revenue | 1.6 | 1.5 |
| Pr/Book | 1.4 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 15.1% | 9.8% |
| PBT | 9.8% | 15.0% |
| EPS | 10.1% | 15.3% |
| DPS | 7.1% | 9.9% |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-07 | 4.99 | 1.34 | 1.07p | 15.0 | 0.6 | +24% | 0.100p | 0.6% |
| 31-Dec-08 | 5.51 | 1.53 | 1.22p | 15.6 | 1.1 | +14% | 0.15p | 0.8% |
| 31-Dec-09 | 5.47 | 1.04 | 0.93p | 11.6 | n/a | -24% | 0.17p | 1.5% |
| 31-Dec-10 | 5.93 | 1.00 | 0.89p | 14.0 | n/a | -4% | 0.17p | 1.4% |
| 31-Dec-11 | 6.83 | 1.10 | 0.98p | 10.7 | 1.1 | +10% | 0.18p | 1.7% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-12 | 7.50 | 1.26 | 1.13p | 10.8 | 0.7 | +15% | 0.20p | 1.6% |
| 31-Dec-13 | 7.85 | 1.47 | 1.32p | 9.3 | 0.6 | +17% | 0.22p | 1.8% |
Copyright © 2012 FactSet Research Systems Inc. All rights reserved.
| Directorate Change | 27-Mar-2012 | 07:00 | RNS |
| Preliminary Results | 27-Mar-2012 | 07:00 | RNS |
| Holding(s) in Company | 16-Mar-2012 | 14:07 | RNS |
| Revenue jumps at Vindon Healthcare | 07-Sep-2011 | ShareCast |
| First Derivatives non-exec pockets £550,000 | 07-Jul-2011 | ShareCast |
| Vindon's profits steady in subdued markets | 29-Mar-2011 | ShareCast |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 12.25p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 12.25p |
| 52 Week Low | 8.75p |
| Volume | 4,784 |
| Shares Issued | 88.85m |
| Market Cap | £10.88m |
| Beta | 0.05 |
| RiskGrade | 90 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Strong Buy | 1 |
| Buy | 0 |
| Neutral | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 1 |

| Latest | Previous | |
|---|---|---|
| Final | Final | |
| Ex-Div | 06-Jun-12 | 01-Jun-11 |
| Paid | 29-Jun-12 | 30-Jun-11 |
| Amount | 0.18p | 0.17p |
| Time | Volume / Share Price |
| 14:11 | 4,784 @ 12.00p |
| Chair | Liam Ferguson |
| Finance Director | Jonathan Emrys Scopes |
You are here: research